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Glycomics is the systematic study of glycosylation in the context of a 
whole cell or organism.  Glycosylated proteins are estimated to make up 50% of 
all proteins and cover the outside of the cell.  Functional roles in glycosylation 
have been noted in pathogenesis, metastasis, and embryogenesis.  However, the 
structure of these carbohydrates has been difficult to study due to the chemical 
nature of carbohydrates.  Lectins, carbohydrate binding proteins excluding 
antibodies and enzymes, can be utilized to study glycosylation in a high 
throughput manner using a microarray format.  Glycans, the carbohydrates 
attached to a protein or lipid, are not synthesized from a template.  They are 
added co- or post-translationally by a concerted set of enzymes in the secretory 
pathway.  In addition, the glycan structures may be altered by metabolism or 
trafficking. 
 Cell type specific glycosylation has long been hypothesized due to 
observations of bacteria homing to tissues.  We use lectin microarray technology 
to define the glycosylation in a subset of the NCI-60, a set of cell lines from 
different tissues.  Using a customized gene expression microarray, we identify 
cell type dependent glycosylation genes and observe evidence of cell type 
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dependent spliceforms for an O-glycosylated mucin.  Data from the lectin 
microarray and a published gene expression data set were integrated using 
Generalized Singular Value Decomposition (GSVD), a linear matrix 
decomposition method.  We have successfully decomposed the data into 3 cell 
type dependent meta patterns that segregate by glycosylation family.  
Correlation projection of the genes and subsequent gene ontology enrichment 
suggests that genes in different pathways covary with the types of glycosylation.  
An inverse relationship was revealed for the N- glycosylation pattern between 
the SVD of the lectins and the GSVD of the genes and lectins together.  Whereas, 
the relationship was correlative for O-glycosylation, which was clearly illustrated 
in biplots. This work argues that types of glycosylation are regulated by different 
mechanisms in different cell types.         
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Chapter 1: Introduction 
 
Glycomics is the study of glycans, complex carbohydrate structures bound 
to proteins and lipids on the cell surface, at a systems level.  An estimated 50% of 
all proteins are glycosylated1.  Changes in glycosylation have been observed in 
tumor cell metastasis, embryogenesis and pathogenesis1-3.  Well established roles 
of the glycans include ensuring proper protein folding and stabilizing a ligand 
for binding4.  Recently, a number of exciting studies have defined functional 
roles, beyond supporting roles for proteins, for the glycans themselves5,6.   
Glycomics faces two challenges distinct from those of genomics and 
proteomics.  First, individual monosaccharides, with a few exceptions, are 
chemically identical isomers composed of the same number of carbon, oxygen 
and hydrogen atoms.  In addition, the manner in which two monosaccharides are 
linked together to form branched, non-linear glycans can vary in structurally 
distinct ways.  These structural aspects can be biologically important.  The avian 
flu virus prefers sialic acid with an α2,3 linkage to galactose which is found at 
high levels in the bird gut.  Human lungs, on the other hand have an α2,6 linked 
sialic acid preventing invasion7.  These qualities historically made glycans 
difficult to analyze by the available analytical methods. Secondly, glycans are 
produced without a template, unlike RNA and proteins.  The branched 
oligosaccharides are synthesized by addition of a monosaccharide to a substrate 
oligosaccharide by transferase enzymes.  The biosynthetic pathway for N-
glycans in which a precursor is co-translationally attached to a protein at an 
asparagine (Nitrogen) has been modeled under static conditions as a modular 
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process through the secretory pathway8.  The pathway for O-glycans 
which are post-translationally attached to proteins at a serine or threonine 
(Oxygen) has not been elucidated, however, dynamic regulation and 
translocation of transferases involved in O-glycosylation during EGF activation 
has been demonstrated9.   In addition, the availability of sugar precursors can 
also influence glycan structure at the cell surface10.  Thus, there are many factors 




With a few exceptions, the monosaccharides that glycan are composed of 
are chemical isomers of each other.  These monosaccharides are linked together 
though the anomeric carbon, adjacent to the hemiacetal oxygen at position 1, 
either equatorially or axially by a glycosidic bond (α or ß conformation, 
respectively).  In addition, the monosaccharides could be linked to one or 
multiple of the 3, 4, or 6 carbon positions to create branched structures.  In the 
case of terminal sialic acid, linkage can occur at position 8.   
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Figure 1.1:  Illustration of an O-glycan with 2 conformations.  Sialic acid which is 
modified by an N-acetyl group is also shown.   
 
Additional compounds, such as phosphate and sulfate, may also modify the 
glycans and affect their function.  Laine performed a simple calculation of the 
number of possible permutation for a hexamer of each type of biopolymer.  The 
results were 4096 hexanucleotide permutations, 64 million peptide permutation, 
and 1.44 x 1012 hexasaccharides taking the linkage and branching capabilities of 
carbohydrates into account11.  Whether or not all of these structures occur in 
nature is unknown due the technical difficulty of analyzing glycans, however, 
some estimations have been made. 
Based on the number of carbohydrate enzymes, which are considered 
highly specific, an estimate was made that no more than 500 distinct glycan 
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structures existed in nature.  However, the number of known glycans recently 
exceeded that number suggesting either unknown carbohydrate enzymes…   
Cummings estimated the number of glycan determinants, or informative units of 
carbohydrates, as 700011.  This estimate was not only based carbohydrate 
enzymes, but on the carbohydrate binding specificity of any carbohydrate 
binding protein including lectins.  The impetus to predict glycans from the 
carbohydrate transferases comes from the fact that there are so many distinct and 
highly specific transferases.  In humans, there are over 300 carbohydrate 
biosynthetic enzymes12.  The enzymes in N-glycosylation are largely conserved in 
mammals (even down to yeast) in terms of sequence.  However, glycan 
composition is lineage specific.  For example, yeast glycans are mostly composed 
of mannose whereas humans have complex glycan structures (Fig. 1.2).13
 
 Figure 1.2:  A typical yeast high mannose glycan is shown on the left which can 
be compared to the mammalian complex glycan on the right.  
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The conservation of glycan synthesis enzymes by sequence does not adequately 
reflect their diversity.  A recent examination showed that some of the enzymes 
have lineage specific paralogs14.   In yeast, as expected, the mannose transferase 
enzyme is expanded compared to other species.  In mammals, this is the case for 
the polypeptide GalNAc transferases involved in O-glycosylation. 
 Recently genome wide association studies have unveiled significant 
consequences for dysregulation of glycosyltransferases.  Two mutant polysialic 
transferases were discovered in a patient with schizophrenia.  Polysialic acid has 
been well studied in embryonic neuronal cell migration.  These chains are known  
prevent intracellular interactions during developmental stages6.   During 
embryonic neuronal cell migration, the polysialic acid chains on the neuronal cell 
adhesion molecule (NCAM) are significantly longer than in adult NCAM.    The 
two mutant polysialic transferases discovered affected the length of the polysialic 
acid chain in vitro.  The length of the polysialic acid affected the concentration of 
neurotrophins bound which could have an effect on the pathophysiology of 
schizophrenia.   Clearly, the wealth of information from genomic wide 
association data which has only become available with cheaper sequencing 
technologies will play a large role in understanding glycosylation.   Glycomics, 
however, is still in its infancy as the tools to evaluate these structures are 





EXISITING TECHNOLOGIES FOR GLYCOMICS 
 
Several technologies have been developed to deal with this problem, 
including tandem mass spectrometry, frontal affinity chromatography, glycan 
and lectin microarrays7,15-18.  Although automated glycan annotation programs 
have been developed, mass spectrometry is still time consuming due to the 
sample preparation necessary to distinguish between conformations17.  Glycan 
arrays are printed with oligosaccharides and have been used to profile the 
specificity of lectins19.  A lectin microarray approach has been developed in our 
lab and in others to provide a method for rapidly detecting overall changes in 
glycosylation using carbohydrate binding proteins16.  Many of the plant lectins 
are commercially available and range in specificity.  Some lectins are highly 
specific whereas others have multiple affinities20.   This provides an information 
dense pattern to infer cell surface glycosylation. 
Several groups are developing approaches to systems level glycomics21-25.  
Thus far, most studies have focused on validating a single protein or glycan 
modification.  In the most comprehensive study, qRT-PCR was used to quantify 
levels of approximately 700 glycosylation related genes and N-glycans in 4 
different mouse tissues23.  In most cases, the transcription levels of the genes 
corresponded well with expressed levels of the glycan structural element they 
targeted.  For certain pathways, the gene transcript levels were shared across 
tissues.  In contrast, for terminal glycosylation genes, transcript levels varied 
across tissues.   Two examples where the transcript levels were not reflected in 
the glycan structure were oligomannose in the liver and sialic acid levels in the 
kidney.  The authors propose that enlarged Golgi and Endoplasmic Reticulum 
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organelles that lead to an excess of untrimmed N-glycan precursors are the cause 
of the raised oligomannose levels.  The discrepancy in sialic acid levels remains 
unexplained.  In addition, the authors were restricted to N-linked glycosylation 
due to the difficulty in sample preparation of O-linked glycans and lipids for 
mass spectrometry, their method of glycan structural analysis.  Despite the 
limitations, the study provided promising evidence that gene transcript levels 
will largely explain N-glycosylation levels.  
With these considerations in mind, we decided to pursue a glycomics 
approach using a whole genome expression microarray and the lectin microarray 
technology developed in our lab to examine the regulation of glycosylation in 
different cell types.  To do this, we chose the NCI-60 cell lines, which are a set of 
59 immortalized cancer cell lines distributed by the National Cancer Institute.  A 
wealth of data is available for this cell line set, including mRNA data, miRNA 
data, DNA fingerprinting, proteomics, copy number variance and 
chemoselectivity.  The cell lines represent 9 different tissues, with multiple cell 
lines in each type (Table 1.1).   We hypothesized that glycosylation is cell type 
dependent and that we could infer aspects of glycan regulation through the 
integration of gene expression data.  We chose a matrix decomposition method 
that does not require intensity thresholding to integrate the data due to concerns 
regarding the low copy number glycogenes.  Further considerations and results 










Cell Type  Cell Lines  
Leukemia  CCRF-CEM, HL60, K-562, MOLT-4, RPMI-8226, SR  
Lung  A549, EKVX, HOP-62, HOP-92, NCI-H226, NCI-H23, NCI-
H322M, NCI-H460, NCI-H522  
Colon  COLO-205, HCC-2998, HCT-116, HCT-15, HT29, KM12, SW-
620  
CNS  SF-268, SF-295, SF-539, SNB-19, SNB-75, U251  
Melanoma  LOX-IMVI, MALME-3M, M14, MDA-MB-435, SK-MEL-2, SK-
MEL-28, SK-MEL-5, UACC-257, UACC-62  
Ovarian  OVCAR-3, OVCAR-4, OVCAR-5, OVCAR-8, NCI/ADR-RES, 
SK-OV-3  
Renal  786-0, A498,  SN12C, TK-10, UO-31, ACHN, CAKI-1, RXF-393  
Prostate  PC-3, DU-145  
Breast  MCF-7, MDA-MB-231, MDA-MB0468, HS578T, BT-549, T-47D  
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Chapter 2:  Lectin Microarray 
 
Technologies that allow for the high-throughput assessment of 
glycosylation are critical to a systems-based examination of the glycome.  
Accordingly, our laboratory developed lectin microarray technology as a new 
method for glycomic analysis.  The lectin microarray has been used to 
characterize the glycosylation of whole cells, bacteria, virions, and tissues.  This 
chapter will provide a brief history of the lectin microarray with a primary focus 
on optimizing methods for piezoelectronic printing and developing protocols to 
increase versatility and speed of analysis. 
 
LECTIN MICROARRAY TECHNOLOGY 
 
Lectins are proteins, exclusive of antibodies and enzymes, that bind to 
carbohydrates.  They are comprised of several families and have affinities in the 
micromolar to mM range20.  Although this is low by comparison to antibodies 
(µM – nM), biologically relevant lectin and carbohydrate interactions are 
multivalent, resulting in higher apparent affinities.  For example, multiple viral 
hemagluttinins bind to multiple carbohydrates on the surface of a host target cell 
during viral invasion26.  With this strength in numbers in mind, it is easier to 
imagine how small changes in the total, localized carbohydrate landscape or 
subtle changes in structure via linkage and conformation between two 
monosaccharides, which themselves are chemical isomers, are functional.  One of 
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the advantages of using lectins in an array format is that the lectins are 
concentrated in the array spot creating an artificial multivalency.   
The lectins printed on the microarray are predominantly commercially 
available plant lectins, which bind mammalian carbohydrate structures for 
reasons currently unknown27.  One theory is that the plant lectins which are 
highly concentrated in seeds have co-evolved with the mammalian gut 
carbohydrates to protect the seeds by toxicity.  Examples of toxic plant lectins 
include the Ricin toxin which comes from the Castor bean and the lectin from the 
elderberry plant.  The lectin specificities printed on the microarray can range 
from highly specific (HPA – terminal αGalNAc) to a range of specificities (WGA 
– βGlcNAc, sialic acid, GalNAc)28.  The Helix pomatia (HPA) lectin from edible 
snails is a great example of a lectin from a non-mammalian source that is highly 
specific to mammalian lectins.  In fact, the HPA lectin has been used in cancer 
prognosis29,30.  The binding specificities for some of the lectins on our microarray 
are broad and there is some redundancy, but in most cases, lectins with similar 
specificities cluster together.  Even with these limitations, we have been 
successful in forming biological hypotheses and validating them31.  This is a 
reflection of how much is left to be discovered in the field.  Many of these 
research avenues were previously impossible due to the technology gap which 
the lectin microarray has helped to fill.   
Lectin microarrays were conceptually inspired by gene microarrays.  The 
power of the gene microarray relies on printing a single gene to a specific 
location or address allowing for high throughput screens32.  Their ease and 
successful use in generating biological hypotheses encouraged the development 
of antibody, protein, and cell arrays.  Lectin microarrays make use of the 
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infrastructure of supporting technologies related to gene microarrays, such as 
slide scanners, labeling dyes and image processing.  Although gene microarrays 
and their applications have changed since their invention, much of the out-of-the 
box analysis involves the assumption of a nearly normal distribution and the 
ability to synthesize random probes as controls33,34.  These are two factors that 
have influenced my treatment of lectin array data.  At the time of lectin array 
invention, we could not say a priori that the lectin microarray distribution would 
be normal due to the number of lectins on the array, multivalent aspects of 
lectins and the unknown nature of biologically presented carbohydrates. 
In our proof of concept work, we printed a panel of nine lectins using a 
manual arrayer on epoxide slides.  We hybridized Cy labeled glycoproteins and 
inhibited these using 100mM monosaccharide to show that the binding event 
was glycosylation related16.  We then expanded our lectin panel and began 
printing using the ArrayIt SpotBot, a microarray plotter that contacts the slide to 
deposit the lectin35.  Spot quality, in terms of the shape distribution of the lectin 
has a serious impact on the data quality.  In early microarray experiments, the 
“coffee ring” or donut effect was often observed36.  This refers to spots that have 
a higher fluorescence along the circumference of the spot.  The “coffee rings” 
approach a bimodal distribution which results in underestimating the true mean 
fluorescence, high error between the medians of replicate spots, and it is difficult 
to transform into a normal distribution37.  While that is an extreme example 
which can be experimentally remedied with the right print conditions, it 
illustrates the importance of the signal distribution within the spot.  This is 
particularly important with the lectins which have heterogeneous physical 
properties which result in lectin dependent signal distributions.  This could affect 
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the error distribution across the set of lectins in an array which has wider 
implications for testable comparisons between them.   
Dual color, ratiometric microarray experiments were an established 
method for accommodating spot morphology issues38.  In dual color 
experiments, a sample is labeled with one dye and the reference is labeled with 
the opposite dye and the two are then hybridized simultaneously (Fig. 2.1). 
 
 
Figure 2.1: Dual color experimental schematics.  A sample and a reference are 
labeled with different dyes and hybridized simultaneously to the 
same array.    
 
If the experiment is a dye swap, the dyes are swapped in a paired array, so the 
sample has the dye that the reference had in the first array and vice versa39.  The 
dye swap experiment is one of the simplest, least biased methods to account for 
the difference in dye fluorescence , which is why we chose it.  After segmenting 
the spots with a mask in Genepix, the average of the log2 ratios of each dye 
swapped pair is clustered and used to compare carbohydrate signatures40.  In the 
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dual color method, the carbohydrates of the two samples are in competition with 
each other.  This allows more subtle changes or increases in carbohydrates to be 
semi-quantified, because of the nature of lectin specificity, in which multiple 
affinities can be observed.  This was the case for wheat germ agluttinin (WGA) 
lectin binding of a dual color experiment hybridizing both the Lec8 CHO cell line 
mutant against the Pro-5 parent.  When either cell line was hybridized alone in a 
single color experiment, there was no observable difference between WGA 
signals.  However, with dual color hybridization, we observed the expected 
decrease in WGA binding for Lec8 which was validated by lectin histology.   
 
M VS. A PLOTS 
 
In addition to the use of dual color experiments to limit spot morphology 
differences, dye swap experiments allow an experimenter the ability to deal with 
dye bias.  Dye bias occurs because the Cy dyes have different strengths and 
labeling efficiencies39,41.  In other words, when scanned at the same gain using 
photo multiplier tubes, the Cy5 yields lower signal than Cy3.  In a gene 
microarray experiment, it would be easier to adjust for dye differences without a 
swap because it is easier to define an expectation based on housekeeping genes 
or other controls.  It is possible to adjust the laser powers so that the ratiometric 
values are 1 for an array where a reference is labeled in each dye and hybridized 
against itself.  However, there can be some slight differences in dye incorporation 
across a set of samples, so including a dye swap adds some certainty to the 
observed differences.  Dye swap experiments make two assumptions: 1) the 
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incorporation of dye is the same for all particulates in the sample and 2) there are 
no other variables that contribute to the dye bias.40  We accept the first 
assumption because the proteins and lipids are assumed to be randomly 
distributed between the cell membrane lamellae.  The protocol for making these 
lamellae includes lysing the cells by sonication which should disrupt any 
microdomains with particular protein enrichment.  To address one aspect of the 
second assumption, data from a sample labeled with both dyes hybridized to the 
same array (self-self hybridization) is graphed in an M vs. A plot, where M = log2 
(R/G) and A = log2√  . 42   Spot to spot variation is more easily visualized due to 
a rotation of the data.  In addition, M vs. A plots are useful for determining non-
linear affects with increasing intensity.  The M vs. A plots for self-self 
hybridization of 3 different cell lines hybridized at highly separated times were 
all centered around zero in a straight line as they should be for good arrays (Fig. 
2.2).  There are some slight differences between the plots.  The plot of the p19 cell 
line experiment shows some labeling differences, which you can see from the 
two distinct populations.  This was a very early microarray hybrization, 
however, so it is possible that my technique was not good.  The plots of the hESC 
and H9 are differently shaped which suggests that the distribution of signals is 
different, although they both center around 0.  This highlights some of my 




Figure 2.2: M vs A plots of various self versus self dual color experiments 





We recently switched from a contact to a non-contact, piezo plotter 
(GeSIM NanoPlotter 2.1) which required significant optimization of lectin 
microarray printing.  Microarray plotters dispense probes onto a modified glass 
slide using a tip or many tips. These tips can either be in contact with the slide 
surface or dispense by either ink jet or piezoelectronic mechanisms.  In both 
cases, the lectin activity decreases with print time, which should be minimized as 
much as possible.  As there can be print to print variation, it is preferable – 
though not always possible- to print slides for the same experiment at the same 
time.  Thus, the print time must be optimized.  To reduce time using either 
technology, one must use multiple tips.   In the case of contact printing 
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technology, this limits array formats to the geometry of the printhead. This  is not 
always ideal for multiple array slides and it increases the amount of probe 
needed.  For non-contact arrayers, the faster method is still simultaneous 
dispensing from both tips, although it is not technically limited to it.  
Unfortunately, we have found unacceptable differences between lectins printed 
from different tips and have been trying to increase the print speed in other 
ways.  The considerations for printing with a non-contact printer are quite 
different from those of a contact printer.  One key consideration concerns the 
voltage and voltage pulse length applied to the tip when dispensing.  These 
parameters can affect the quality of the array alignment and size of the spots.  In 
piezoelectronic printing, the speed of the probes-in-flight is determined by the 
applied voltage to the tip.  The probes-in-flight are small enough that they are 
sensitive to small fluctuations in air flow requiring that they be dispensed at high 
enough velocity.   Additionally, increasing the voltage to increase the speed and 
thus the accuracy of spotting, actually influences the size of the spot in a lectin 
dependent manner.  Several of the lectin spots get smaller as the dispense 
velocity increases, which makes sense given that our slides are coated with a 
hydrogel (Fig. 2.3).   Thus, there is a tradeoff between the accuracy of the spot 




Figure 2.3: A lectin microarray printed with the piezoelectric printing technology 
at the same voltage.  The lectins vary in size across the array. Two 
different lectins are highlighted in blue and orange. 
 
 
  To compare the effect of voltage and pulse on different lectins and 
between two different tips, I printed WGA onto the first 12 blocks and DSA on 
the last 12 blocks (Fig. 2.4a).  For two spot rows of 17 columns, 34 spots total, the 
voltage was varied in increments of 10V starting at 70V, which is the 
recommended minimum voltage for that size of tip (NanotipA).  The pulse was 
either 50ms or 60ms.  Both pins were mounted and dispensed at the same time 
making every other block row from a different tip.   I hybridized one Cy5 labeled 
glycoprotein to each array, either ovalbumin or asialofetuin.   
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Figure 2.4: Test of print variation by tip. A) schematic of slide layout and an 
array hybridized with a glycosylated protein. B) Number of spots 
with high mean-median correlation per set of pulse, voltage 
conditions. 
I used the mean-median correlation, an indicator of the normality of the 
distribution of fluorescence values and their normality, as a measure of the spot 
quality36.  In Excel, the lesser (either the median or the mean) was divided by the 
greater of the two values.  If the quotient was greater than 0.9, the spot was 
labeled “good,” otherwise it was labeled “bad.”  The number of “good” spots 
were counted for each set of conditions and compared.  The highest number of 
good spots was 178 for 70V and 60ms pulse and the lowest was 96 spots for 70V 
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and 50ms pulse.  Although the total number of spots for each set was 544, 
meaning that in the best case on 1/3 of the spots were good, I was using these 
lectins because they had morphology issues in a previous print.  It’s possible that 
the number of good spots is related to the position of the rows since the best set 
was nearly in the middle at rows 9 and 10 (Fig. 2.4b).  This could occur from 
some affect related to mixing during the hybridization that would favor the 
middle of the well.  However, that trend does not seem to hold, as rows 8 and 9 
are actually worse than 6 and 7.  Local background would not influence this 
analysis because I did not use the background subtracted fluorescence values.  
Comparing the two tips for all pulses and voltages (4352 spots), the new pin 
printed more good spots than the old pin, 606 and 455 respectively.  For the best 
set (P=60, V=70), a trend of a decrease in percent error going down the slide (Fig. 
2.5a).  There is a slight decrease inversely associated with fluorescence (Fig. 2.5b), 
however, the fluorescence intensity and location are not independent because 
DSA which has higher fluorescence was printed at the bottom of the slide.  Given 
that the M vs A plots for the lectin arrays do not normally show non-linear 
affects, print location which in this case corresponds to print time appears to 
have an effect on spot quality.  In the practical sense, what matters more is that 
there is a correlation with printing longer and lower errors.  We generally run the 
printer for overnight washes as recommended, but that does not include 
dispensing from the tip.  In the future, it may help to preprint with water on a 




            Figure 2.5: Graphs of error against A) block position which corresponds to 












High throughput is a relative term.  While lectin microarrays are higher 
throughput than many existing technologies for glycan structural estimation, the 
image and data processing afterward can cause bottlenecks in the workflow.  
Spot-finding algorithms rely on distinct edges or high spot size and spacing 
uniformity.  In most lectin array experiments, some of the lectins are negative 
and their edges difficult to distinguish from the background, making them hard 
to detect.  In addition, the flight path of the droplet can be influenced by several 
variables and the arrays are not always aligned perfectly.  Ultimately, a lot of 
manual alignment is required, which can be time consuming.  
A third dye can be added to the print buffer to use for alignment issues.43 
 In this case, a positive binding event during hybridization is not needed to 
detect the spot.  The spots from the third dye should also be closer in 
fluorescence intensity to each other, making it easier to adjust the contrast at 
which to run the spot-finding algorithm.  To investigate the use of a third dye 
applied to lectin microarrays, I printed one lectin that normally has uniform 
spots and another lectin that can have irregular spot morphologies (WGA and 
AOL, respectively).  The 5-aminofluorescein diffused into the background (Fig. 




Figure 2.6: WGA and AOL lectins printed with varying concentrations of 5-
aminofluorescein dye (blue).   The array was hybridized with Cy5 
labeled glycoprotein (red). 
 
The Alexafluor-488 labeled bovine serum albumin (BSA) diffused at the 
same rate as the lectin, which is evident from their overlapping signals.  The 
BSA-A488 spots had strong edges which were easily picked up by the automated 
spot -finding algorithm, resulting in highly aligned spots.  The composite pixel 
intensity (CPI) is a threshold for determining an edge, where CPI=0 is the most 
permissive.  At a CPI=0, several smears were counted as spots (Fig. 2.7).  
Whereas at CPI=100, a few spots were missed resulting in 97% alignment.   At 
CPI=500, the properly aligned spots drops to 88%.Based on this data, a CPI 
between 0 and 100 would minimize the amount of time during manual 
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alignment although the optimal CPI may need to be determined for each print.  
Unfortunately, there is some bleedthrough from the Alexafluor-488,. 
However,this could be fixed with filters with narrower bandwidths or using a 
different dye.  
 
 
Figure 2.7: Lectin arrays were printed with Alexafluor 488 labeled bovine serum 
albumin.  Automatic alignment can be optimized using the 





IMPROVED MEMBRANE PREPARATION 
 
Labeled cell membrane preparations are often hybridized to lectin 
microarrays.  The membranes are isolated by lysing the cells via sonication, 
ultracentrifugating the solution at 100,000 xg for 1 hour and resuspending the 
pellet prior to labeling.  This process results in heterogenous lamellar blebs. (Fig. 
2.8a)  Previously, the membranes were isolated after lysing the cells using a 
probe tip sonicator into the sample that was inserted into the sample and 
required a volume of at least 1 mL.  In addition, the concentration of cells must 
be at least 1 million cells/mL in order to be above the critical micelle 
concentration (CMC), the concentration necessary to maintain micellae based on 
the biophysical properties of the lipids and transmembrane proteins involved.44  
These properties can be extrapolated to lamellae.  Since we are working with a 
complex set of lipids and proteins derived from a whole cell, we had to 




Figure 2.8: A) Electron micrograph of cell membrane preps.  Scale is 500nm.  B) 








A change in micellar integrity should result in a change in the lectin array pattern 
because only the proteins are labeled in the micellae, so glycolipid carbohydrate 
signals would be lost or could possibly compete with the glycoprotein signal.  I 
found that below a concentration of 1 million cells/mL the lectin array pattern 
was significantly different.  Thus, with the probe tip sonicator, we are limited to 
samples of at least 1 million cells.  Certain types of cells, for example, neuronal 
and primary cell lines, cannot grow to a high cell density.  I tested sonication 
using a device that can sonicate several eppendorf tubes of sample at the same 
time (Tweeter).   I sonicated H9 and Jurkat cells using the Tweeter at a 
concentration we often use of 10 million cells in 3mL.    I varied the pulse time (5, 
10 seconds) and the power (50, 100%) and kept the rest time for all samples at 15 
seconds.  We sonicate with 5 second pulses with 10 second rests as described in 
the user manual when using the probe tip sonicator.  Using cells from the same 
flask, I also prepared them using the cell membrane preparations using the probe 
tip sonicator and labeled all the samples at the same time.  The probe tip and 




 Lectin microarrays have enabled our lab to address fundamental 
questions in glycobiology, and allowed us to engage in fruitful collaborations.  
Over the years, the lectin technology has improved significantly.  The printing 
technology is now more reliable and effective and additional carbohydrate 
binders, such as bacterial adhesions although not discussed here, have been 
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developedfor lectin microarray use.45,46  Overall, the lectin activity has improved 
with non-contact, piezoelectronic technology.  However, there are some 
considerations for printing lectins related to the voltage and pulse when using 
this printing techology, which I hope I have illustrated.  In addition, the arrays 
have expected M vs. A plots and are not subject to severe non-linear effects, so in 
most cases, depending on the sample, should not require data smoothening.  
While the technology continues to mature in its application, several issues need 
to be solved. Among these are  optimizing the print time and conditions, 
resolving data processing bottlenecks, and miniaturizing sample preparation 
protocols to be useful for low density samples. Also,   laser dissected tissues 
















Lectin array printing  
 Plant lectins (EY Laboratories, Vector Labs, Sigma) are printed in 0.5, 1, 
and 2 mg/mL concentrations on Nexterion H slides (Schott).  We are currently 
printing with a piezoelectric NanoPlotter 2.1 (GeSIM).  The slides are printed at 
45% relative humidity on the plotter’s cooling deck which keeps the circulating 
water at 10°C (Fig. 2.9).  Ideally, we print the slides in 24 hours, which is 
approximately the time it takes to print 14 slides with 90 lectins, or less.  Prior to 
printing, the NanoPlotter is placed on standby mode and the tip is washed every 
30 minutes overnight.   
 One of the main advantages of the NanoPlotter is the flexibility of the 
print conformations and substrates.  It is possible to print onto any target and in 
fact, grab coordinates from an irregular object in an image and print those 
coordinates into prototype silicon microwells, which we have done.  The 
NanoPlotter also comes with a series of programs for spotting from multiple tips 
simultaneously or sequentially.  However, for ultimate flexibility in source plate 
aspiration and spotting, the Multitask program can be used.  This program was 
developed by HTS resources to run spotting programs using XML markup code.  
I have used this to make program that results in an array where a singular spot 
of lectin is printed after the last lectin rather than printing 3 spots of the same 
lectin in succession.   We did this to distribute the lectins around the slide to 
better account for background variation.  The XML transfer lists command the 
NanoPlotter to spot in a line by line fashion with source plate, block, and spot 
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coordinates.  I have written multiple scripts in Python to generate these transfer 
lists.     
 Another aspect of the NanoPlotter is the Stroboscope test.  The 
Stroboscope takes 4 images of rapidly dispensing drops.  Parameters of the drops 
are measured for consistency.  If the variation in the Y location of the drops is too 
high, the NanoPlotter will not continue printing that sample.  At the end of a 
program, a correction file is run with the coordinates for the missing spots.   
 








Membrane isolation and labeling of mammalian cells 
 Adherent cells are harvested by scraping to avoid Trypsin which cleaves 
glycans in a biased way.  The cells are then pelleted and resuspended in a 
phosphate buffered saline at a concentration of at least 1 million cells/mL.  The 
cells are lysed by sonication and the membranes are pelleted from the solution 
by ultracentrifugation at 100, 000 x g for 1 hour at 4°C.  The pellet is resuspended 
in carbonated buffer (pH = 9.3) for labeling.  6µg per mg of protein of either Cy5 
or Cy3 dye (Amersham Biosciences) is added.  The dye and the membrane 
particulates are incubated at room temperature for 30-45 minutes.  The reaction 
can be quenched with Tris buffer.  The samples are then dialyzed overnight with 
a microdialyzer at 4°C.  Following dialysis of the free dye, the samples are 
aliquotted, snap frozen in liquid N2 and stored at -80°C.   
 
DSA and WGA spot quality assessment print 
The arrays were hybridized with 10µg of glycoprotein, either Ovalbumin 
or Asialofetuin.  As per usual, the slide was incubated at room temperature for 2 
hours and washed 5 times with PBST (0.05% TWEEN) and once with PBS prior to 
scanning on our Genepix 4300A.  The spots were segmented in Genepix Pro 7.0 
using circular alignment with some manual adjustment.  The left column of the 
slide was lower in intensity than expected so I only used the middle and right 
columns for analysis (16 blocks total).  The mean median correlation was used to 
avoid contribution of background variation in the assessment of the spots.  In 
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addition, the data for the whole slide can be compared without regard to the 
glycoprotein identity. 
 
General segmentation of data and analysis 
 The slides are scanned using a GenePix 4300A Scanner (Molecular 
Devices).  The data is segmented from the image file (TIFF) of the scanned slide 
in Genepix Pro 7.0 using circular alignment.  The alignment is manually checked 
and corrected if necessary.  The results are exported in text file and analyzed, for 
the most part, in Excel.  Local background subtracted median fluorescence is 
tested for outliers using the Grubbs test.  Signals are counted as positive if the 
SNR ≥ 3 in the Genepix report.  Dual color experiments are usually dye swap 
experiments.  In dye swap experiments we calculate the average of the Log2 
ratios for the pair.35,40 The averages are hierarchically clustered in Cluster 3.0 
using the Pearson centered metric between arrays and average linkage.47  To 
cluster the lectins, we use the Euclidean distance.      
                             
3rd dye printing 
 Well defined Alexafluor 488 bovine serum albumin (BSA) was purchased.  
BSA is a globular protein that is not glycosylated and has been used in protein 
array print buffers as a passivating agent.48,49  The Alexafluor BSA was added to 
the print buffer at a concentration of 100ug/mL.  
Tweeter specifics 
 I put the samples in the positions closest to sonicating source which are 
the highest power because the resistance increases along the metal holder.  The 
samples were sonicated with 3 pulses at 100% power.  I have observed some 
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variability with using lower power percentages.  The length of the pulses and 
rests (5 seconds and 10 seconds, respectively) are the same as they are for probe 






Figure 2.10: Tweeter sonicator.  Eppendorf tubes can be placed in the holes of the 
holder.   The tubes closer to the power source experience less 






Chapter 3: Whole Genome Expression Array 
 
 Gene expression microarrays are highly affordable and robust, and since 
their invention in the mid 90’s, have matured as a technology with clinical 
utility.32,50  As the technology transitioned, there were mixed reports about the 
reproducibility of the experiments of different labs and platforms.  Each 
microarray platform has a different approach to designing the gene expression 
probes.  These probes must match part of the sequence of a gene or predicted 
gene while allowing for technical aspects of the labeling of isolated RNA, which 
could result in shortened transcripts.  The Affymetrix microarray platform uses 
many (approx. 20) short probes of 20-25 bases and calls genes based on the 
average of full matches minus mismatch probes to reduce the contribution of 
background and cross-hybridization.  The Nimblegen platform uses 60mer 
(bases) probes that are designed to contain 37 overlapping 24mer sequences.  In 
addition, the companies often sell labeling and kits for isolating RNA from 
samples, which could add variation.  The MAQC study was initiated to address 
previous reports of inconsistencies between labs and platforms and published its 
first report in 200651.  The MAQC studies have shown that for the same sample 
there is a high level of technical consistency between array platforms and sites 
despite different labeling protocols.  The results suggest that a portion of those 
discrepancies are real transcript levels and could be biologically relevant.  In 
light of the ENCODE project, it is apparent that there are more and different 
transcripts than previously predicted.52 
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 Gene lists can vary and the coverage for some biological processes is not 
complete in standard microarray platforms.  This is the case for glycosylation.  In 
fact, a custom array targeting glycogenes was curated and designed using the 
Affymetrix platform by the Consortium for Functional Glycomics.21  Today, it is 
possible to affordably buy and even customize expression arrays with probes for 
44,000 genes.  We chose to study the regulation of glycans in different cell types 
using the NCI-60 set at the gene transcript level using a customized whole 
genome expression array.  This chapter will discuss my work with available gene 
expression sets for the NCI-60 and the design of a gene expression microarray 
customized with a full set of glycogenes.  
 
PRELIMINARY EVALUATION OF EXISTING DATA  
Glycosylation as a cell type marker has long been theorized.  One 
observation related to the establishment of this theory is pathogen tropism, or 
host selection.  In fact, E. coli targets different tissues by using fimbriae that 
target carbohydrates in a specific tissue.13  The P and type-1 fimbriae target the 
urinary tract by binding to Galα1-4Galβ- and Manα1-3(Manα6)Man glycoforms, 
respectively.  The E. coli S fimbriae targets neural GM2 and GM3 gangliosides 
andthe K99 fimbriae bind to intestinal cell wall gangliosides.  Carbohydrate 
changes have also been observed in embryogenesis, when cells begin to identify 
and distinguish themselves from other types.1  In Drosophila, cell identities are 
established initially by a gradient which is essential to proper polarization and 
can affect the downstream stages when cells are further differentiated.  
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Significantly, a gradient of a sialic acid analog has been observed in Drosophila 
larvae.24  Thus, there are many provocative observations that suggest a cell type 
dependent sugar code, however there has not been a systematic study of it. 
Although many of the details of carbohydrate regulation have yet to be 
fully understood, there is a fair amount of evidence for regulation of the 
glycosyltransferases at the transcript level for N-glycosylation.8,23,53  We decided 
to look at the contribution of glycogenes to cell type from published gene 
expression array data.  Ross et al. hybridized the NCI-60 to an array with 
approximately 8000 gene probes.54  One result of the study was that 1160 out of 
8000 genes clustered by cell type.  Within this set of genes, the ovarian, leukemia, 
colon, CNS and renal cells clustered by cell type.  We evaluated this based on the 
clusters below the Pearson Critical Value of 0.062 (P = 0.05).  The Pearson Critical 
Value is a threshold of significance calculated for a particular number of samples 
and P-value using a t-test.   To see how many of those were glycosylation related 
genes, I extracted out the glycosylation related genes from the whole set of 
positive signals and compare their clusters to the published cell type clusters.  
This resulted in 166 glycosylation related genes out of the approximately 4800 
genes with a significant fold change. 
 The glycogene subset was hierarchically clustered.  The Pearson critical 
value was calculated for the smaller number of genes and used as a threshold of 
significance for the gene clusters (fig. 3.1).  
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Figure 3.1:  Cluster of arrays in Ross data based on glycogenes.  The Pearson 
critical value for 166 genes is displayed. 
  
The colon, leukemia and melanoma cell lines clustered in both the glycogene 
subset and the original dataset.  The renal and ovarian cell lines did not cluster as 
well in the subset and were in fact, sparsely distributed across the clusters.  
However, the glycogene subset for these data only included 14% of the 1160 
glycosylation related genes which have been curated by the Consortium for 
Functional Glycomics (CFG).  This list includes glycosyltransferases, 
glycosidases, glycoproteins, lectins, sulfate transferases and other relevant 
genes.Thus, the underrepresentation of glycogenes might explain the lack of 
expected correlation between the renal and ovarian cell lines. Another 
possibility, is that other genes influence the regulation of glycosylation.  This has 
recently been illustrated with regard to a Fucose 1,3 addition which is important 
in neural development of flies. Using a forward genetic screen in Drosophila for 
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this addition which results in physically deformed 3rd instar larvae 166 genes 
relevant to the proper addition of Fucose 1, 3 were identified.24  These included 
master regulators, some of which were actually cell cycle dependent genes that 
have no prior association with glycosylation.  Although this paper was published 
after our experimental design, it provides a promising outlook for the 
completion of our experiments which will be able to look at multiple 
glycosylation structures via the lectin microarray.   
 
CUSTOM ARRAY DESIGN 
 
 Our objective was to customize an array with all of the glycogenes on the 
glycogene array (version 4.0) which was curated by the Consortium for 
Functional Glycomics in addition to the other genes.21  First, I matched RefSeq 
IDs from the CFG list to the Nimblegen catalog resulting in 820 matches.  A few 
were no longer active RefSeq IDs due to redundancy.  The remaining gene IDs 
were largely UCSC browser IDs which is a less stringent catalog than RefSeq.  
RefSeq is a curated database of non-redundant gene sequences submitted to the 
International Nucleotide Sequence Database Collaboration.55  It does not include 
isoforms or splice variants.  The Nimblegen whole genome expression array 
actually includes some redundant genes which may have been identified by 
different groups.  These genes could be on different locations and different parts 
of the chromosome.  For these reasons, Nimblegen does not accept gene name 
IDs when designing custom probes and only accept chromosome locations.   I 
used the UCSC table browser to retrieve the exon sequences for the UCSC IDs. 
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Nimblegen selects probes for targets within 1500 base pairs from the 3’ end on 
the gene.  This makes the probe less sensitive to splice variants which generally 
occur on the 5’ end.  Through a complex set of rules related to the uniqueness of 
the probe and optimal chemical properties, such as melting temperature and 
unlikelihood of secondary structure, they select the best set of probes for the 
target gene.  Many of the resultant glycogene probes include probes to multiple 
exons of the same gene.   
  
 
VALIDATING LOW COPY NUMBER GLYCOGENES 
 
Many glycosylation related genes are low copy number.  To insure that 
that the low copy genes were reverse transcribed, I used both OligodT and 
random primers in a 1:1 mix.23   I validated the presence of low copy genes by 
PCR amplification of the double stranded cDNA.  Rft1, Chst14, and St6GalNAc1 
were chosen based on their relatively lower expression levels yet presence in all 4 
mouse tissues.23  Rft1 is the gene encoding an endoplasmic reticulum 
transmembrane protein involved in flipping the lipid linked N-glycosylation 
precursor into the ER prior to elaboration.  It is highly conserved down to yeast 
and its expression would be expected in all cell types.  Chst4 is the gene for a 
dermatan sulfotransferase and St6GalNAc1 transfers CMP-sialic acid to both N 
and O linked glycans with an α2,6 linkage.   PCR amplification of Rft1, Chst14 
and St6GalNAc1 dsCDNA from a total RNA isolation confirmed the presence of 
Rft1 and Chst14 (Fig. 3.2).  
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Although the PCR resulted in a streak, the two streaks were centered at the 
expected transcript lengths (183 bases for Rft1 and 970 bases for Chst4).  
Unfortunately, I could not confirm the presence of St6GalNAc1 by PCR although 
I repeated it several times.  The CFG glycogene array list only includes one entry 
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for St6GalNAc1, so if there are splice variants, they are not currently known.  
Sialic acid terminates glycan chains, except in the case of oligomeric polysialic 
acid, and as a family of glycosyltransferases, the sialyl transferases are 
differentially expressed in different tissues.   It’s possible that although 
St6GalNac1 was expressed in the 4 different mouse tissues that this gene is not 
expressed as widely in humans.  Taken together, the results of the Rft1 and Chst4 
PCR confirm that low expression transcripts were present in our samples.  In 
fact, the probes targeting all three genes were above background but below the 
mean expression value in our arrays which were hybridized using the same 
protocol for cDNA synthesis. 
 
ANALYSIS OF GLYCOGENE PROBES 
The data from our gene expression array were examined for cell type 
dependent signatures and the overall success of the probes.  To briefly describe 
the data collection, matched samples from the NCI-60 were collected and split 
into cells for the lectin array and cells for the gene expression array.  The total 
mRNA was isolated and labeled cDNA was synthesized.  The samples were 
checked for quality prior to hybridization.  The data for each gene array was 
extracted from the image and the quality of the hybridized array was evaluated 
using the NimbleScan software.   
  
I selected the glycogenes from the data for the 49 cell lines which passed 
all quality control measures.  The glycogenes consisted of 2994 probe sets, many 
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of which targeted different exons of the same gene.  64% of the glycogene probes 
were not overexpressed in any of the arrays (Fig 3.3).  This was determined by a 
stringent cut-off of 2-fold over the mean for each probe.  The 2-fold over the 
mean cut-off was recommended by the MAQC consortium as threshold that 
reliably identifies biologically important data.  This does not exclude the 
possibility that probes (or genes) below the threshold could be important.  
However, clustering methods are limited by the amount of computation power 
required for large data sets.  In addition, too many low expressing probes could 
overwhelm signatures and make the cluster uninformative.    
 
Figure 3.3: Histogram of the number of cell lines that a probe was positive for. 
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Another 8.0% of the probes were only positive for one sample.  76% of the 241 
probes that were positive for on 1 gene, were probes designed to a specific exon 
of one of the missing glycogenes rather than one of the higher confidence probes 
provided by the Nimblegen gene catalog.  Approximate half of those singular 
signals were from 2 cell lines, UACC-257 and NCI-H460 (53 and 60 probes, 
respectively).  Although these cell lines passed the uniformity threshold, the 
difference in their overall expression from the other cell lines is suspicious.  They 
were included analysis for the time being.  On the other hand, just 1.1% of the 
glycogenes were broadly overexpressed in 45-50 samples.  
 Genes that were shared between 90% of the samples included a number of 
sulfate transferases and mucins and lacked proteoglycan synthesis genes 
(Appendix A).  Notch 2, Notch4, Jagged 2 and fibroblast growth factor receptors 
are involved in proliferation, as would be expected for cancer cells.  Proteoglycan 
synthesis is often associated with cell proliferation and angiogenesis as well, but 
their upregulation was not shared amongst all cell lines.  It is possible that their 
loss was necessary for adaptation to cell culture where cells are grown two 
dimensionally on a culture dish rather than three dimensionally.  The lectin array 
comparisons of cells grown two-dimensionally in culture plates and three- 
dimensionally in Matrigel showed no differences in cell surface glycosylation 
(personal communication, Monika Abramszuk).  However,   The 
glycosyltransferases that are upregulated include UGCGL2 and GALNT10, 
which are a glucosyl ceramide and polypeptide GalNAc transferase, respectively.   
GALNT10 is involved in mucin synthesis so their coexpression is 
understandable.   
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The positive glycogene probes were clustered (Fig 3.4).  The whole set was 
highly correlated (r = 0.59).  The leukemia and melanoma cells group together, 
but because the overall correlation is high, they do not segregate from the rest of 
the group.  The rest of the cell lines are intermixed by type.   It is possible that 
there are still cell type dependent signals that cannot be determined by 
hierarchically clustering the over 900 positive glycogene probes.   I filtered the 
data by various parameters.  Thresholding the data for genes that were positive 
in five cell lines did not improve the cluster nor did taking the new probes out.  
Methods other than cluster can be used to evaluate the data, however, I wanted 
to compare our data to the cluster of the Ross data glycogenes, presented earlier.   
  
 




The frequency distribution of the number of cell lines that a gene is 
positive for shows an overall decline (Fig. 3.3).  However, there is a hump for 
genes that are positive in 3 to 10 cell lines, which is similar to the number of cell 
lines in one cell type.  With the exception of the prostate cell type which are only 
2 lines, the rest of the cell types contain 5 to 10 cell lines.  I filtered for genes that 
were positive in 5 to 10 of all 49 cell lines and took a subset of cell lines with 
distinct gene expression signatures, which was determined from previously 
published data.  The cell lines are the leukemia, colon, melanoma and renal cell 
types.  The genes were ordered by cell type and clustered by gene (Fig. 3.4).  
Visually, there are some cell type dependent signatures in the heatmap.  72% of 






Figure 3.4: Hierarchical 
cluster of positive 
glycogenes 
thresholded by number 
of positives for a subset 



















To look at these cell type dependent signatures, I counted positives by cell 
type and filtered the data for genes that were positive in only one or two of the 
cell types.  The genes are segregate to these cell types by class of glycoprotein 
(Appendix A).  The colon and renal cells both have overexpressed C-type lectins 
(calcium binding) and mucins.  Notably, the cell type specific and shared set of 
C- type lectins and mucins are distinct. The shared mucins include MUC1 and 
MUC5B.  Furthermore, the cell type specific mucins actually segregate between 
the renal and colon cells.  MUC 17 and one of the MUC5B probes are 
overexpressed in renal cells.  Whereas MUC6 and a different MUC5B probe are 
overexpressed in the colon cells.  Interestingly, the MUC5B probes correspond to 
different probe locations.  Two of the probes were custom probes designed from 
the same gene location, but correspond to two different exons from one of the 
newly designed UCSC probes.  The other MUC5B probe was designed to the 
more frequently included Refseq probe.  Mucin genes have high levels of 
polymorphism and have been observed in tandem repeats.  In fact, several 
subpopulations of the HT-29 colon cell have been isolated where differences in 
expression of MUC1 and MUC5 were observed with age (passage number).56  
However, the transcript levels highly correlated to the mucins expressed, 
suggesting transcriptional regulation.  Leukemias generally express simple O-
glycans where the first sugar added is GalNAc.   The leukemia cells exclusively 
overexpress sugar transporters.  GALE is an epimerase which converts glucose 
or GlcNAc to galactose or GalNAc.  The other two genes do not have well 
defined functions.  SLC35C2 is overexpressed in ovarian cancer and is related to 
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maintaining oxygen levels.  This could be rationalized by the fact that leukemias 
are blood cells.  The last sugar transporter is CMP-NeuAc hydroxylase protein 
homolog.  A loss of the catalytic N terminal of CMP-NeuAc hydroxylase 
(CMAH) is a human specific mutation resulting in a lack of N-glycolylneuramic 
acid (Neu5Gc).57  It was thought that Neu5Gc was not expressed in humans; 
recently, however, Neu5Gc has been found in the serum of cancer patients.58  The 
melanomas exclusively overexpress a mannose transferase (DMP3) and a 
GlcNAc transferase that transfers GlcNAc exclusively to O-linked mannose (table 
2).  DMP3 is the dolichol mannose transferase responsible for transferring 
mannose to the mannosylated N-linked precursor.  These two mannose 
transferases are part of two separate pathways, N-linked and O-linked.  Their 
overexpression together may suggest a feed-forward regulatory loop based on 




The cell lines share proliferation related genes such as the Notch genes 
and a few glycosyl transferases and glycosidases (Table A1).  The shared glycan 
biosynthesis genes are mannosidase I (MANIA2), heparin sulfate 2-O-
sulfotransferase 1 (HS2ST1), UDP-glucose ceramide glucosyltransferase like 2 
(UGCGL2), polypeptidyl GalNAc transferase 10 (GALNT10), and carbohydrate 
sulfotransferase 10 (CHST10).  No particular pathway is overrepresented.  
MANIA2 is associated with the N-linked glycosylation pathway.  GALNT10 is 
one of the many ppGalNAc transferases in the O-linked glyocosylation pathway.  
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UGCGL2 is involved in ceramide synthesis in glycolipids.  The lack of more of 
the N-linked glycosylation pathway genes might be related to the high cutoff for 
positives.           
The overlap of positive signals of all genes for our data to previously 
published Liu et al. data for one cell line was only 25%. The percentage is not 
unusual given the previous debates on reproducibility of data, which is not an 
issue of technical reproducibility.  In addition, immortalized cancer cell lines can 
have different growth properties dependent as they are cultured in different labs 
with different culture conditions.59  It is also possible that the probe locations, or 
what part of the gene the probe targets, could affect overlap in the results.    
The exon targeted by the probe also seems to vary in a tissue specific 
manner.  This is true not only for MUC5B but for ABCF1 and CD44.  The probes 
were designed from the 3’ end to avoid splice forms which normally occur from 
the 5’ end.  There are few examples of 3’ splicing although it could be a 
possibility.  Given that the mucins are highly duplicated in the genome, it might 
be interesting to consider the context of those genes within the genome to see 
whether they vary.  Perhaps there are differences in enhancers at different 
promoter sights that lead to different copies being transcribed in different cell 
types and as the cell line ages.  In the case of alternative splicing, splicing 
enhancers could also vary with cell type or age.   
The differential expression of C-lectins and mucins in different cell types 
is quite interesting.  C-lectins play a role in the homing of metastatic tumor cells 
to tissues.60  The glycosylation of mucins has been difficult to study due to the 
complications in cleaving the O-glycans.  Recently, using a new method, 
differences in the glycosylation of mucins in leukemia and epithelial cell lines 
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were found.56  Our data shows that mucins are cell type specific suggesting that 
these mucins have specific roles.  Whether that is determined at the glycan or 
transcript and how that is regulated is a growing field of research.   
The cell type dependency of the probe location may explain the lack of 
correlation between gene calls and quantative PCR of glycogenes.  Nairn et al. 
found a low correlation between the two, however or array suggests that the 
discrepancy was related to the number of positive gene calls.  Positive genes are 
called by a platform dependent algorithm.  The comparison was made with an 
Affymetrix array from the Consortium for Functional Glycomics which consisted 
of several short probes to different probe locations.  Given that approximately 8% 
of our probe sets, which are sets of 3 highly specific probes to 1 exon, are cell line 
specific, our results illustrate the need for a glycogene array with probe locations 














Clustering glycogenes from 2000 Ross Data  
I downloaded genes with a 2-fold change in the Ross et al. data set from 
the Stanford Microarray Database, which is a generally accepted threshold for 
change in microarray experiments.  Unfortunately, since the data was from an 
early gene microarray experiment, it was difficult to match the probe 
annotations.  Many of them were EST tags which only referenced back to the 
array design without a RefSeq or Entrez gene ID, which would have made it 
easier to match to the list of glycogenes provided by the Consortium for 
Functional Glycomics.  I decided to match partial terms related to glycosylation 
to the gene descriptions which were provided.  For example, I used the search 
terms “glyco*,” “mann*,””gluc*,” where * is the wildcard designation.  To ensure 
that I had exhausted the search terms, I checked my terms against the 
glycosylation relevant biosynthetic pathways in the KEGG database.  The 
glycogene subset was hierarchically clustered using the Pearson centered 
correlation and average linkage 
 
Removal of probes from the Nimblgen Catalog 
Since the arrays were originally maximized for number of probes, we had 
to find the space for the new probes after they were designed.  We began by 
using a published dataset and selecting genes that did not change and had a ratio 
between -0.5> x >0.5 for all of the NCI-60.  We then manually selected 300 of the 
more than 1000 genes with low variance to remove from the Nimblegen gene 
catalog to make sure that we left in transcription factors or anything with a DNA 
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binding domain.  We also removed a few of the random control probes which 




Culture of the NCI-60 
The NCI-60 cells were cultured in RPMI (Cellgro) with 10% fetal bovine 
serum (Atlanta Biologicals) and 1% L-glutamine.  Multiple people in the lab 
participated in growing the cells which were harvested at 80-90% confluency.  
For the RNA isolation, at least 5-10 million cells were trypsinized and stored in 
RNAlater (Qiagen) for up to 1 year.  To minimize person to person variation, I 
performed the isolations, labeling and hybridization of sample to the expression 
arrays myself.  The cells were isolated using the RNEasy mini-kit for total RNA 
isolation (Qiagen).  I avoided precipitation of the RNA after isolation because the 
conditions can vary depending on the size of the RNA, which lead me to believe 
that there was some uncertainty regarding bias after precipitation.  If the salt 
content was too high after the kit, I isolated the RNA from the stored stock again 
to insure the collection of a high quality data set.  Occasionally, it was necessary 
to culture and harvested a different set of cells.   
 
 
RNA quality evaluation 
Successful RNA isolation was evaluated by spectrophotometry, using a 
Nanodrop.  The relative absorbance of 280nm/260nm can be used to evaluate the 
presence of proteins, which have amino acids that absorb at 280nm.  Ideally, this 
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ratio should be around 2, although a ratio of 1.8 is considered good.  Similarly 
the presence of salts, which would disrupt downstream processing, is indicated 
by a high 230nm/260nm.  The appropriate ratio is, once again, close to 2.  If the 
total RNA isolation had two good ratios, the RNA quality was further tested 
using the Bioanalyzer, which is essentially a miniaturized electrophoresis gel.  
Using a combination of factors which includes the peak ratio for ribosomeal 
subunits, the Bioanalyzer calculates an RNA integrity number (RIN).  Samples 
with an RIN of 8 or higher with a maximum value of 10 were used.   
 
cDNA synthesis and labeling 
 The total RNA isolations were reverse transcribed with Superscript III 
(Invitrogen).  Following the protocol in the Nimblegen expression guide, second 
strand synthesis was done using DNA Ligase and DNA Polymerase I 
(Invitrogen).  The double stranded cDNA was labeled using a One-color labeling 
kit (Nimblegen).  12 of the cell lines were tested for good cDNA quality using the 
Bioanalyzer DNA 7500 kit (Agilent).  All of them were good quality as evaluated 
by the specialists at the Genome Technology Center at the NYU Langone 





The primers were designed using NCBI primer blast.  I input the RefSeq 
ID for the gene and selected the highest ranked primer pair (Fig. 3.5).  These 
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primers were designed with a Tm = 70C and so that any unintended targets 




Figure 3.5: Primer design for low copy glycogenes. 
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Gene array quality control 
The data from the hybridized gene arrays was segmented in NimbleScan 
and the quality was evaluated according to their criteria for uniformity prior to 






















Chapter 4:  Integration of Glycomics and Genomics 
 
One challenge of interpreting microarray data is determining the 
biologically significant signals from the noise.  As with any large data set, there is 
a tradeoff to setting signal thresholds which results in either false negatives or 
false positives.  In addition, the usage of hierarchical clustering for classification 
has limitations.  By definition, more similar sets of signals are grouped with each 
other before being compared and grouped to the next most similar set of signal.  
This process reduces the visibility of secondary patterns that might shared 
between two sets of signals that initially get separated into groups based on a 
primary pattern.  Given that some of the glycosylation related genes have low 
copy number levels, reduction of noise without signal thresholding and 
sensitivity to lower signal patterns is of the utmost importance.  Singular Value 
Decomposition (SVD) is a method that separates overlapping patterns into 
constituent metapatterns with an associated significance.61  The focus can be 
shifted to the visualization of the significant patterns which could have biological 
or experimental relevance.  Thus the signal is extracted from the noise 
independent of a threshold related to signal intensity.  This chapter will discuss 
the application of SVD to the interpretation of the lectin array data from our lab 
and gene expression data published by another lab. 
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SINGULAR VALUE DECOMPOSITION :  LECTIN ARRAY  
Singular Value Decomposition (SVD) is a linear transformation of a data 
matrix into principal components (eigengenes and eigenarrays) with a 
diagonalized matrix of the contribution of each pattern.  In its application to 
microarray data, the principal components represent a pattern across either all 
arrays or all genes62.  Mathematically, this is represented as:  
                       M = UVT 
While similar to principal component analysis (PCA), the values in the Σ matrix 
facilitate the selection of most significant patterns.  SVD has been used to study 
the yeast cell cycle and successfully identify novel genes involved in the 
process.62  Generalized SVD works on similar mathematical principles and can be 
used to integrate matrices with a shared set of conditions63.  
The biological meaning of SVD can be difficult to interpret without 
recognizable patterns.   In the case of the cell cycle data, the first two eigenarrays 
were sinusoidal, the hallmark of a cyclical process.  With this in mind, we 
wanted to maximize our chances of seeing a pattern.  To do this, we decided to 
focus on a subset of 4 cell types (melanoma, leukemia, colon and renal) which 
had distinct gene expression patterns in the Ross data.  Each cell line was part of 
a dye swapped pair against a pooled reference that was hybridized to the lectin 
array.  This pooled reference included one cell line from 6 different types that 
had a stable glycomic signature over multiple passages.  The hierarchical cluster 
of the subset reveals some grouping by cell type which suggests a cell type 
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dependent glycosylation code (Fig. 4.1).  In addition, it corroborated prior data 









After a preliminary examination with hierarchical clustering, I decomposed the 
data using SVD (Fig. 4.2). For the SVD analysis, the cell lines were grouped by 
subset prior to decomposition.  The resultant V matrix had 29 eigen-lectins which 
collectively describe patterns of lectin binding across the set of 29 cell lines.   
 





Figure 4.2:  Close-up of the first 5 eigen-lectins in the SVD of the subset.  The 2nd, 
3rd, and 4th eigen-lectins show some cell type variation.  The 5th is 
included for comparison. 
 
The first eigen-lectin represents shared signals across the array (Fig. 4.2).  
Accordingly, little variation is observed.  The second, third, and fourth eigen-
lectins covary with cell type.  The second eigen-lectin exposes a lectin binding 
pattern that is higher in the colon and leukemia cell lines, but lower in renal and 
melanoma.   
The renal and colon cells are relatively higher than the leukemia and 
melanoma cells for eigen-lectin 3.  The overall pattern for eigen-lectin 4 is hard to 
interpret, but there the signals are clearly lower for leukemia.  The eigen-lectins 
are ordered by significance.  While some techniques have been developed to 
threshold eigen-patterns based on their significance which can be calculated 
from the diagonalized  matrix, the cell type dependent eigen-lectins are 
amongst the top and their relative significance can be presumed.64   Moreover, 
their clear cell type dependent pattern suggests biological importance. 
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INTEGRATION OF A SUBSET 
With this preliminary data in hand, we decided to integrate the lectin 
array data with a high quality published dataset.65  This dataset was released 
while we were collecting our own and includes both mRNA and miRNA 
isolations hybridized to and Agilent platform.  The whole genome expression 
array data previously available for the NCI-60 was hybridized to a non-
commercial microarray which would have made annotation matching extremely 
laborious.54  The Agilent platform is widely utilized and the probe IDs have been 
deposited in a number of databases including DAVID.  DAVID is a resource 
provided by the NCBI which houses a number of different resources including 
an ID converter.66,67   Agilent probe IDs can easily be converted to Entrez gene 
IDs. 
 To integrate the data we used a generalized version of SVD (GSVD) (Fig. 
4.3a). This method has been successfully used in the integration of yeast and 
human microarray data.68  GSVD integratation of two distinct datasets also 
illustrates a key difference between principal component analysis and singular 
value decomposition.  Principal Component Analysis decomposes the data into 
two matrices and lacks the  matrix, which is not only useful for calculating 
significance but a scaling matrix.61  Without it, two datasets on different scales 
could not be compared well.  Even with a ratiometric approach, the data from 
two different microarrays could be on different scales, which is even more 
probable for microarrays of different types, such as the lectin and gene arrays.   
For the GSVD integration, the data was again organized by cell type.  The 
resultant matrix of eigen-gene-lectins and arrays has 3 cell type dependent eigen-
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gene-lectins (called eigen-celltype from this point onward) which appear to be 
better defined than the eigen-lectins in the SVD of the lectins alone.  I projected 
the vector of a lectin signal for all cell types onto the eigen-celltypes to calculate 
the correlation of each lectin signature to the eigen-celltype pattern (Fig. 4.3b).69  
This is measure of the gene or lectin similarity to the cell type pattern.  I filtered 
the correlation matrix for genes and lectins that were exclusively positive to one 
of the 3 eigen-celltypes when compared to the first 4.  I chose a stringent filter 
because signals could poorly correlate to multiple eigen-celltypes and many of 
the lectins have overlapping specificities. 
 
  
Figure 4.3:  A) Close-up of the first for eigen-celltypes in the GSVD of both the 
lectins and the genes. B) Projection correlation was calculated for the 
lectins.  Lectins exclusive to an eigen-lectin are summarized. 
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The lectins which correlated to the second eigen-celltype and therefore 
were higher in the renal and melanoma cell lines were lectins that bind to N-
glycans.  More specifically, there is a strong high mannose signature (CVN, SVN, 
GRFT, Calsepa, AMA, NPA, UDA, HHL) and α2,6 sialic acid (SNA, PSL, TJA-I).  
Experiments in our lab using the melanoma cells have separately observed a 
high mannose signal.  In the third eigen-celltype, the lectins that were exclusive 
to that eigen-celltype were terminal GalNAc specific (VRA, PTL-II, HAA) which 
implies O-linked glycans.  Although there are only 3 exclusive lectins, a less 
stringent filter to include any positively correlated lectin includes more O-linked 
specific lectins.  This eigen-celltype is higher in the renal and colon cells.  The 
fourth eigen-celltype is higher in glycolipid binding lectins (TKA, PapGII) and 
higher in the colon and melanoma cell lines.   
ENRICHMENT ANALYSIS 
The genes were treated the same way as the lectins.  They were projected 
onto the eigen-celltypes and the genes that were exclusively correlated to one 
eigen-celltype were examined further.  Looking for enrichment of annotations 
associated with a biological pathway is an easy and informative way to study 
large data sets.  The gene list was uploaded to the DAVID database and their 
ontologies were retrieved.  I chose DAVID, rather than another gene ontology 
database, because it displays the known shared ontologies of clustered genes in a 
matrix format.  This is particularly important for glycogenes which are not 
always listed as the same process in gene ontology databases, for example in the 
case of sialic acid.70  The enriched gene ontology clusters have an enrichment 
score, which allows you rank the clusters by significance although other clusters 
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could still be interesting.  The cluster enrichment scores are the mean of the P-
values of all the annotations in the cluster.  The P-values are calculated from the 
percentage of annotations of a particular biological pathway observed in the 
gene set compared to the percentage of those annotations that would be expected 
from the human genome. 
Taking the top 3 gene clusters from each set, I was able to observe some 
interesting trends (Table 4.1).  
 
 
Table 4.1: Summary of top 3 gene ontology clusters in DAVID for each eigen-
celltype. 
 
Genes related to organelle lumen are highly expressed in all three eigen-
celltypes.  The biosynthetic pathway of glycosylation occurs in the secretory 
pathway, through the endoplasmic reticulum and golgi, so it is encouraging 
organellar lumen classified genes are being expressed.     
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 As I said previously, each eigen-celltype corresponded to a different 
family of glycosylation.   Interestingly, the most significant gene ontology 
clusters were from distinct pathways.  Genes involved in cytoskeletal and 
microtubule regulation, as well as ribonucleotide binding proteins, were 
enriched in the same eigen-celltype that correlated to N-glycosylation.  However, 
the enrichment score for the clusters in eigen-celltype 2 are low compared to 
eigen-celltype 3 and 4.  The highest enrichment score in that set is 4.09 compared 
to enrichment scores with maximum values of 55.83 and 24.92, for eigen-
celltypes 3 and 4.   Since eigen-celltype 2 is has a higher significance than eigen-
celltypes 3 and 4, it represents a more general process, which might explain the 
low enrichment scores.  This suggests less influence from other cellular processes 
for N-glycosylation or that the regulators are too few to be clustered in the 
ontology enrichment.  As previously introduced, the N-glycosylation pathway is 
highly conserved and can be modeled as a modular synthetic route through the 
secretory pathway.   In addition, studies of N-glycosyslation have already shown 
a high correlation with transcript level and glycan structure.  So the N-
glycosylation pathway appears to be well defined and for the most part, 
regulated at the transcript level of the genes in the pathway.   
The gene list for this eigen-celltype includes several genes that would be 
expected with N-glycosylation, such as class II alpha mannosidases which are 
involved in trimming the tri-mannose N-glycosylation core.  The function of the 
class II mannosidases is not as well known as the class I mannosidases which 
signal misfolded proteins for degradation.71   α-mannosidase II is the second 
mannosidase in the N-glycosylation pathway which cleaves mannose on the 
third branch.  If the mannose is not cleaved, the branch is not elaborated further, 
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resulting in a partially elaborated and stunted hybrid glycan.  Inhibition of α-
mannosidase II in HEK293 cells results in hybrid N-glycans.72   
Eigen-celltype 3 corresponded to o-glycosylation and was enriched in 
ribosomal and RNA processing genes.  The regulation of O-glycosylation is not 
well known.  The first step in O-glycosylation is the transfer of a UDP-GalNAc 
with one of over 20 polypeptide galnac transferases.73  These transferases can 
compensate for each other making knock-out studies difficult to interpret.  
Currently, little is known of the required sequence for O-glycosylation, in part, 
this is due to the difficulty of cleaving O-glycans in an unbiased way from a 
protein.  Some differential binding of groups of the polypeptide Galnac 
transferases has been demonstrated.  However, the requirement is only a basic 
residue two residues from the serine or threonine suggesting promiscuity and 
redundancy.  Recently, evidence of COP-I retrograde translocation  of the 
polypeptide GalNAc transferases from the Golgi the trans endoplasmic 
reticulum upon EGF activation was reported.  EGF activation resulted in higher 
overall amounts of o-glycosylation.74  The promiscuity and redundancy of the 
polypeptide galnac transferases could be regulated through trafficking which 
might change in dynamic circumstances.  This type of system could rapidly 
generate variability which could modulate signals.  It has been suggested that 
carbohydrates are participate in “analog” type signaling.   
Intriguingly, a cluster of genes with O-GlcNAc transferase (OGT) and 3 
different TPR domains were identified within the same eigen-celltype.  O-
GlcNAc is a small glycan involved in signaling whose roles have not been 
completely elucidated.  It is thought that the TPR domains participate in 
substrate selection and they themselves are substrates for OGT.75,76  O-GlcNAc is 
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required for the aggregation of untranslated ribosomes to stress bodies so it is 
interesting that it coexpresses with translational machinery in the eigen-celltype 
which is accociated with O-glycosylation.77     
 The lectins that correlated to the 4th eigen-celltype represented 
glycosylated lipids.  Mitochondrial genes were the top gene clusters for this 
eigen-celltype.  Mitochondrial associated membranes (MAM) which bridge 
mitochondria to the ER have been associated with lipid synthesis and trafficking 
of lipids during stress.78  Evidence of a glucosyl and GalNAc transferase in the 
MAM has been demonstrated.79  The mitochondria are highly influenced by 
metabolism and this data suggests that might also influence lipid glycosylation.  
Perhaps, this offers an explanation for the increased GalNAc in breast cancer, 
which is visible by HPA binding.  
 The patterns that were decomposed in the SVD of the lectins are actually 
different from those in the GSVD of the lectins and genes together (Fig. 4.4a).  
The second eigenvectors are reciprocal patterns.  The third eigenvectors are 
similar in pattern.  The fourth set is mixed with one half of the signals in 
reciprocity and the other in concordance.  Biplots of the projection correlation of 
each lectin onto the eigenvectors from the decomposition of lectin signals alone 
and with the gene signals provide a better sense of the trend.  The third 
eigenvectors are highly positively correlated to each other as expected (Fig. 4.4c).  
Surprisingly, the exclusive lectins do not overlap as lectins although their 
specificity for o-glycans do to some extent.  HAA,PTL-II,MNA-G, MPA are 
GalNAc binding lectins.  TJA-II and VRA are galactose binding lectins.  The other 
lectins are a combination of glycolipid and N-glycan lectins.  The second 
eigenvectors are negatively correlated in the fourth quadrant which confirms the 
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patterns visible in the heatmaps (Figure 4.4a).  The most extreme fourth quadrant 
lectins have a positive correlation to the eigen-celltype which more closely 
reflects the gene expression and a negative correlation to the eigen-lectin which 
reflects the lectin binding or carbohydrate expression.  Suggestively, at this 
extremity, the lectins largely correspond to high mannose lectins (HHL, SVN, 
GRFT, AMA, TL, UDA).  This could signify that there is high gene regulation of 
the high mannose glycans in renal and melanoma cells.   
No trend in terms of the eigen-celltype versus eigen-lectin biplot is 
observable for the fourth eigenvectors (4-4d).  Perhaps, the relationship with 
metabolism is influencing this distribution.  It will be interesting to see whether 
the breast cell lines are described with this signature, which did not cluster as a 








Figure 4.4: Comparison of SVD of lectin signals and GSVD of gene array signals 
using biplots. 











The biplots from the SVD of the lectins and the GSVD of the lectins and 
genes suggest that the regulation of N- and O-glycosylation which differentiates 
these cell lines is different.  In the case of N-glycosylation, the biplot has a strong 
negative trend which is also clearly visible as a reciprocal relationship in the SVD 
heatmaps.  This suggests pivotal change which would be the case in binary 
decision that is simply regulated by the level of the enzyme.  Given that the N-
glycosylation pathway is highly conserved, regulated at the transcript level and 
sequential, this model makes sense.  We find that binding of lectins with a 
specifity to complex N-glycan structure are inversely correlated to α-
mannosidase expression.  This is expected given the role of α-mannosidase II in 
cleaving a mannose residue from one of the core branches prior to elaboration, 
which leads to the complex N-glycan type.  The high mannose binding proteins 
correlated with the eigen-celltype and α-mannosidase II.  Α-mannosidase II 
levels determine the fate of N-glycans to either a complex or high mannose type.  
This corresponds to what is generally known for the mannosidases which in 
terms of N-linked glycan elaboration is early in the pathway.  In addition, the 
α2,6 sialic acid lectins (SNA, PSL, TJA-I) correlate to the eigen-celltype, but the 
lectins correlated to the eigen-lectin were both α2,6 and α2,3 sialic acid binders 
(SNA, MAA).  The correlated gene list only includes α2,3 sialic acid transferase 
and not α2,6.  This suggests some inverse correlation between the α2,6 and α2,3 
sialic acid transferases.  It is unlikely to be non-specific binding of α2,6 sialic acid 
lectins because 3 of them were correlated to the eigen-celltype.  Sialic acid 
addition is one of the final steps in the N-linked glycan elaboration.  A previous 
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study on N-glycosylation glycomics reported low correlation of transcript levels 
for both oligomannose and sialic acid.  Our integration is more informative and 
shows and inverse correlation between the genes regulating oligomannose and 
their cell surface display.  In addition, our data suggests that a similar 
relationship may exist for the α2,3 and α2,6 sialic acids.   
It would be interesting to consider these trends within the context of the 
other correlated genes.  Although, the cytoskeletal genes are not as highly 
enriched, there may be a few key regulators.  During cell migration, there is 
dynamic feedback between adhesion protein and the cytoskeleton.80  E-cadherin 
is a well studied adhesion molecule with roles in cancer.  Its dysfunction cannot 
be fully explained with genetics or epigentics. Changes in N-glycosylation have 
been implicated with its dysfunction in some carcinomas.2  Although, E-cadherin 
was not in our genelist, it is tempting to speculate on the roles of altered N-
glycans in adhesion molecules.   
The O-glycosylation SVD biplot is linear and positively correlated which 
is promising in terms of understanding the regulation of O-glycosylation.  In 
light of the fact that the gene ontology clusters have high enrichment scores, 
these genes may actually play a large role in the O-glycosylation.  Some of the 
genes in the gene list were expected and confirm that the correlation and 
decomposition was successful.  Two polypeptide GalNAc transferases, 2 and 7, 
correlate to the eigen-celltype, although strangely, none of the mucins do.  Our 
own gene array data suggests cell type specific mucins and some exon 
specificity.  In fact, the mucin signals we observed were all from the custom 
designed probes.  Given the redundancy of the polypeptide GalNAc transferases 
and that the enriched ontologies suggest a role for translation machinery, it may 
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be difficult to make further hypotheses without perturbing the cell.  In addition, 
this data set lacks adequate mucin probes.  In the future, it could be interesting to 
investigate the regulation of alternative splicing of mucins and the relationship of 
mRNA degradation pathways.  In addition, comparing the regulation of mucins 
compared to the regulation of polypeptidyl transferases in creating functionally 




 The SVD and GSVD were performed Mathematic (Wolfram) using the 
built-in function.  The projections were also calculated in Mathematic by taking 
the dot product of the eigen-celltype or eigen-lectin with every lectin and gene. 
The data was filtered in Excel using conditional statements and auto-filter.  The 
genelists were uploaded to DAVID (http://david.abcc.ncifcrf.gov/) for the 












The data suggests that these four cell types have a glycosylation signature 
and suggests that other cell types do as well.  Our data also shows that the 
glycosylation that differentiates each cell type can be decomposed into the major 
glycosylation families, N-linked, O-linked and glycolipid.  Based on gene 
ontology enrichment and biplots of the correlation of each lectin to the eigen-
lectins and eigen-celltypes, it appears that that the glycosylation that 
differentiates these cell types is regulated by different mechanism dependent on 
the glycosylation type (N-,O-, glycolipid).  Although these cells are cancerous, 
they still reveal differences in the regulation of cell type dependent glycosylation.  
In addition, our ability to decompose the data using previously published work 
suggests that these patterns are very strong and that integration with our data set 
may reveal more subtleties.  Extension of the integration to other cell lines and 
using the customized gene array data with more glycosylation probes is planned.  
We may encounter some problems with cell types that are more diverse, such as 
the breast cell lines.  However, we could investigate some of these hypotheses in 
larger, publicly available datasets.  Genome wide association studies have 
illustrated the functional impact of mutations in polysialic acid transferase.  Our 
data suggests cell type specific exons for mucins.  This implies the need for a 
larger cohort which might be publically available.  Alternatively, we could look 
for glycogenes in the copy number variance data for the NCI-60 or sequence our 
own cell lines.  The integration of multiple environmental and hereditary factor 
in the misregulation of the N-glycosylation pathway in the Golgi which explains 
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the pathology of multiple sclerosis is a poignant example of the importance and 
adaptability of glycosylation pathways.5  Our data suggests that the regulation of 
each type of glycosylation pathway, particularly for N- and O- links, is different.  
In the future, we hope to investigate the role of other elements in each pathway 
and any differences that may suggest a difference in the evolution of 
glycosylation pathways.  Other master regulators may be identified and 
perturbed.  Thus, we hope to move toward a model that sufficiently describes the 
regulation of glycosylation in the context of the dynamics in the secretory 
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Sulfo-T CHST10 [carbohydrate sulfotransferase 10] 
Glycoproteins Mucins MUC1 [Mucin 1, cell surface associated] 
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HNRPD [heterogeneous nuclear ribonucleoprotein 
D (AU-rich element RNA binding protein 1, 37kDa]  
xInterleukin & 
Receptors 
IL IL16 [interleukin 16] 
xInterleukin & 
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IL receptor IL6R [interleukin 6 receptor]  
xInterleukin & 
Receptors 
IL IL1R2 [interleukin 1 receptor, type II] 
xMiscellaneous Miscellaneous EIF4G2 [eukaryotic translation initiation factor 4] 
xMiscellaneous Miscellaneous EIF3C [eukaryotic translation initiation factor 3] 
xMiscellaneous Miscellaneous HSP90AA1 [heat shock protein 90kDa alpha (cytosolic)] 
xMiscellaneous Miscellaneous HDLBP [high density lipoprotein binding protein]  
xProteoglycan Miscellaneous CD74 
















Table A2: Cell type specific glycogenes 
CBP:C-Type 
Lectin 








6-MMR MRC1L1 or MRC1  
CBP:C-Type 
Lectin 
6-MMR PLA2R1 (Phospholipase A2 receptor 1) 
CBP:I-Type 
Lectin 
Non-Siglec N-CAM CD56   
CBP:I-Type 
lectin 
Siglec MAG [SIGLEC4A] 
Glycan-
transferase 





Glycoproteins Mucins MUC17 [Mucin 17, cell surface associated] 
Glycoproteins Mucins MUC6 [mucin 6 gastric] 
Glycoproteins Mucins MUC5B [mucin 5 subtype B tracheobronchial] 
Glycoproteins Mucins MUC5B [mucin 5 subtype B tracheobronchial] 




















Notch3 - Short Trans 
Nuc. Sugar Nucleotide 
Synthesis  
CMP-NeuAc hydroxylase-like protein [Cytidine 
monophosphate-N-acetylneuraminic acid 
hydroxylase-like protein] 
Nuc. Sugar Nuc. Sugars 
Transporters 
SLC35C2 [solute carrier family 35 member C2] 
Nuc. Sugar Nucleotide 
Synthesis  






























ABCF1 [ATP-binding cassette, sub-family F 
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